ADIM
NTRS icon

Alpha DNA Investment Management’s Northern Trust NTRS Stock Holding History

Alpha DNA Investment Management’s Portfolio NTRS Stock Details NTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,227
Closed -$741K – 115
2024
Q4 		$741K Buy
+7,227
New +$739K 0.28% 81
2024
Q3 		– Sell
-10,277
Closed -$863K – 236
2024
Q2 		$863K Buy
+10,277
New +$863K 0.34% 65

Other funds holding NTRS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alpha DNA Investment Management's NTRS Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Northern Trust (NTRS) in Q1 2025, closing a stake of 7,227 shares — an estimated $741K sold.

Alpha DNA Investment Management first reported a position in NTRS in Q2 2024 and held it in 2 quarters. The position peaked at $863K in Q2 2024. 784 funds tracked by Wall St. Rank hold NTRS as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Northern Trust position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 7,227 Northern Trust shares in Q1 2025, an estimated $741K.
  • Alpha DNA Investment Management first reported a position in Northern Trust in Q2 2024 and held it in 2 quarters.
  • Alpha DNA Investment Management's Northern Trust position peaked at $863K in Q2 2024.
  • 784 funds tracked by Wall St. Rank held Northern Trust as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.